Copertina

Reply to: Comments on “Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank”

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yuchen Zhang, J. Thomas Brenna, Ye Shen, Kaixiong Ye
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	International Journal of Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank
di: Yuchen Zhang, et al.
Pubblicazione: (2024)

Comments on “Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank”
di: Tomoyuki Kawada
Pubblicazione: (2025)

Metabolomic landscape of overall and common cancers in the UK Biobank: A prospective cohort study
di: Chanchan Hu, et al.
Pubblicazione: (2024)

Association between visceral adiposity index and cancer risk in the UK Biobank cohort
di: Solange Parra‐Soto, et al.
Pubblicazione: (2024)

Associations of sarcopenia, sarcopenia components and sarcopenic obesity with cancer incidence: A prospective cohort study of 414,094 participants in UK Biobank
di: Panagiotis Filis, et al.
Pubblicazione: (2025)

Thirteen simple lifestyle scores and risk of cancer, cardiovascular disease, diabetes, and mortality: Prospective cohort study in the UK Biobank
di: Jie Ding, et al.
Pubblicazione: (2025)

Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort
di: Sofia Christakoudi, et al.
Pubblicazione: (2024)

Reply to: Comments on “Social inequalities in treatment receipt for childhood cancers in Ireland: A population‐based analysis”
di: Michal Molcho, et al.
Pubblicazione: (2024)

Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohort study
di: Panu Aaltonen, et al.
Pubblicazione: (2024)

Prospective Associations of Body Composition and Body Shape With the Risk of Developing Pancreatic Cancer in the UK Biobank Cohort
di: Sofia Christakoudi, et al.
Pubblicazione: (2025)

Post‐acute sequelae of COVID‐19 in cancer patients: Two cohorts in UK and Hong Kong
di: Eric Yuk Fai Wan, et al.
Pubblicazione: (2024)

Reply to ‘Comment on “Plant‐based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study”’
di: Yen Thi‐Hai Pham, et al.
Pubblicazione: (2025)

Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
di: Ylva Naeser, et al.
Pubblicazione: (2025)

The Fibrosis‐4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies
di: Victoire de Salins, et al.
Pubblicazione: (2025)

Associations of diabetes status, duration, and onset age with the risk of lung cancer: Results from the China Kadoorie Biobank study
di: Jian Su, et al.
Pubblicazione: (2025)

The importance of studying the implementation of cancer data standards
di: Travis J. Osterman, et al.
Pubblicazione: (2024)

Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort
di: Robin Reichmann, et al.
Pubblicazione: (2024)

Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study
di: Fudong Xu, et al.
Pubblicazione: (2024)

Comments on “Long‐term use of low‐dose aspirin for cancer prevention: A 20‐year longitudinal cohort study of 1,506,525 Hong Kong residents”
di: Linkun Shen, et al.
Pubblicazione: (2025)

Comments on “Mode of delivery and the risk of lymphoblastic leukemia during childhood—A Swedish population‐based cohort study”
di: Yung Gonzaga, et al.
Pubblicazione: (2025)

Plasma fatty acids depletion: A metabolic signature related to colon cancer
di: Alice Chaplin, et al.
Pubblicazione: (2025)

Significant overall survival benefit with dostarlimab plus chemotherapy in advanced endometrial cancer
di: Mary Beth Nierengarten
Pubblicazione: (2024)

Associations between lifestyle factors and excess mortality of cancer patients in Finland: A pooled analysis of seven population‐based cohort studies
di: Iitu Peltola, et al.
Pubblicazione: (2025)

Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort
di: Shane A. Tinsley, et al.
Pubblicazione: (2024)

Correlation analysis of invasive disease‐free survival and overall survival in a real‐world population of patients with HR+/HER2– early breast cancer
di: Stephanie L. Graff, et al.
Pubblicazione: (2025)

Comment on “Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case‐cohort study”
di: Rui Wang, et al.
Pubblicazione: (2024)

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
di: Cecilia A. Castellano, et al.
Pubblicazione: (2024)

Comments on “Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial”
di: Jingxuan Dai, et al.
Pubblicazione: (2026)

Inequalities in relative cancer survival by race, immigration status, income, and education for 22 cancer sites in Canada, a cohort study
di: Talía Malagón, et al.
Pubblicazione: (2025)

Mental Health Conditions and Incident Cancer: A Prospective Cohort Study of 402,255 UK Biobank Participants
di: Mohammed Sherif Amin, et al.
Pubblicazione: (2026)

Smoking‐independent DNA methylation markers for lung cancer risk: External validation in a large population‐based cohort study
di: Zitong Zhao, et al.
Pubblicazione: (2024)

Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study
di: Xiaojie Liang, et al.
Pubblicazione: (2024)

Reply to “Comments on chemoradiotherapy in IDH wild‐type/TERT‐mutant grade 2/3 gliomas”
di: Jing Zhang, et al.
Pubblicazione: (2026)

Early time of day of administration of immunochemotherapy for enhancing overall survival in patients with lung cancer irrespective of histological type?
di: Francis A. Lévi
Pubblicazione: (2026)

Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
di: Ying L. Liu, et al.
Pubblicazione: (2025)

Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
di: Thu Thi Pham, et al.
Pubblicazione: (2025)

Association between TyG ‐related indices and colorectal cancer risk: A prospective cohort study
di: Runxue Jiang, et al.
Pubblicazione: (2025)

Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi‐cohort validation study
di: Pinli Yue, et al.
Pubblicazione: (2025)

Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom
di: Longgang Zhao, et al.
Pubblicazione: (2024)

Non‐steroidal anti‐inflammatory medication use and endometrial cancer survival: A population‐based Norwegian cohort study
di: Ala Jabri Haug, et al.
Pubblicazione: (2025)